ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Rauscher Disappointed In CREG Progress

October 1, 1976

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

Take Program Direction Away From CCIRC, Form New Group for Clinical Trials, Conferees Suggest

June 6, 1975

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

November 5, 1982